We are a French company dedicated to analysing health big data and developing innovative tools

Our Approach

Our Approach

We
analyze
health big data
economics data
In France
In Europe
In the USA
For
Health
companies
Hospitals
Trade unions
and Authorities
data analyses
methodologies
Statistics
Data Mining
Process Mining
provide
answers
marketing
and sales issues
epidemiological
regulatory
medico-economic
share the results
of the studies
Html5 websites
native iOS Apps

Unrivalled analyses with French health big data

HEVA was the one of the first companies to have a full access to the French database of inpatients (PMSI: Programme de Médicalisation des Systèmes d'Information) in accordance to the French data privacy committee.
We are able to root out the relevant information for epidemio-economic analyses, marketing studies in order to give a new vision for health industries, hospitals and authorities (Patient pathways, trajectories care…)

Since 2005 and the coming of the French DRG prospective payment, this comprehensive database has still enhanced its data, so as to precisely describe the activity of French hospitals with data like diagnosis, surgical procedures, expensive drugs administered, medical devices used, real cost to manage patients, ...

In order to always offer innovative solutions, HEVA has constantly improved its methodology and process to re-invent the using of the health data: following patients during several years, valuation of hospital cost, analyze of compliance of SPC for expensive drugs, performing digital and dynamic maps for trajectories cares and patients pathway, fulfilling of iPad and web solutions.

These new creative and ingenious tools of data visualization enable Health actors to propose groundbreaking solutions for the new actors like regional authorities to work on care cooperation, health care provision, optimization of care regional projects...

Anticipating the controlled liberalization of the data, HEVA already lead up deeper analyses, alone or with its partners.

Employees

Employees

Founded in September 2005 by Ludovic Lamarsalle and Alexandre Vainchtock, both Pharmacist (Pharm.D) and Health economist (Msc).

Employees
19
Health big data
11
1
COO
1
Health Data expert
1
INGENEER
(PhD CANDIDATE)
2
Senior Consultants
6
Data Scientists
(stat / SQL)
Excecutive Assistant
1
Datavisualization Digital
7
2
web / iOS Designer
3
iOS CODERS
2
html coders

Our Data

Our Data
per Year

Stays
200M
Patients
60M
Coding lines
10M
Coffees
20 000
Projects
200

Clients

Clients

ABBVIE ACCURAY AEC PARTNER ALLERGAN AMGEN ANALYSIS GROUP ARS PACA ASEPT INMED ASTELLAS ASTRAZENECA AXELION PHARMA BAXTER BECTON DICKINSON BOEHRINGER INGELHEIM BOSTON SCIENTIFIC BRISTOL-MYERS SQUIBB CELGENE CNAMTS CONCEPTUS COOK CSL BEHRING CYBERONICS DAIICHI SANKYO DEVICOR MEDICAL EHESP EISAI ETHICON FABRE FHF GILEAD GSK HCL HOLOGIC HRA PHARMA IPSEN JANSSEN LEO PHARMA LFB LILLY LUNDBECK MEDPASS MEDTRONIC MERCK SERONO MSD NESTLÉ HEALTH SCIENCE NOVARTIS PFIZER PIERRE FABRE ROCHE SANOFI SANOFI PASTEUR MSD SERVIER SHIRE SIGVARIS SJM SMITH&NEPHEW SNITEM SORIN STARGEN TAKEDA TESSELON WL GORE ZIMMER

Publications

Publications

HEVA contributes to the development of research through publications (Scientific congress, peer reviews…) and its partnership with the French academies. These information, data algorithms and studies allow to beef up our community of Health data.

Publications

Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France
Cécile Blein /Alexandre Vainchtock
BMC infectious disease - 2015

Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalizd in France
Gwendoline Chaize / Alexandre Vainchtock
Europace - 2015

Management of immune thrombocytopenia in adults
Remerciements HEVA
BHJ - 2015

Costs of dengue in th three French territories of the Americas: an analysis of the hospital medical information system ( PMSI) database
Cécile Blein
European Journal of Health economics - 2015

The Cost of Thromboembolic Events in Hospitalized Patients with Breast or Prostate Cancer in France
Alexandre Vainchtock
Advanced in Therapy - 2015

Activity and cost related to hospital management of zona in france: focus on the zona ophthalmic
Alexandre Vainchtock
Geriatr Psychol Neuropsychiatr Vieil - 2014

Tubal sterilization: pregnancy rates after hysteroscopic versus laparoscopic sterilization in France, 2006–2010
Cécile Blein / Ludovic Lamarsalle
Eur J Obstet Gynecol Reprod Biol - 2014

Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France.
Gwendoline Chaize / Alexandre Vainchtock
J Stroke Cerebrovasc Dis - 2014

Evaluating the clinical and economic burden of healthcare-associated infections during hospitalization for surgery in France.
Ludovic Lamarsalle
Epidemiol Infect - 2013

How did chronic hepatitis C impact costs related to hospital health care in France in 2009?
Alexandre Vainchtock / Baptiste Jouaneton
Clin Res Hepatol Gastroenterol - 2013

Economic burden of osteoporosis in women: data from the 2008 French hospital database (PMSI).
Alexandre Vainchtock / Baptiste Jouaneton
Clin Exp Rheumatol - 2012

Burden of breast cancer with brain metastasis: a French national hospital database analysis.
Alexandre Vainchtock
J Med Econ - 2012

Surveillance de la prise en charge de l’hépatite chronique C : analyse des données nationales du Programme de médicalisation des systèmes d’information (PMSI)
Alexandre Vainchtock / Baptiste Jouaneton
BEH - 2012

Economic burden of HPV-related cancers in France
Remerciements HEVA
Vaccine - 2010

Economic burden of anal cancer management in France.
Alexandre Vainchtock
Rev Epidemiol Sante Publique - 2010

Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database.
Alexandre Vainchtock
Head Neck Oncol - 2010

Coût de prise en charge des cancers de la vulve et du vagin en France
Alexandre Vainchtock
Journal d’Économie Médicale - 2010

Vulvar and vaginal cancers and dysplasia in France--an analysis of the hospital medical information system (PMSI) database.
Alexandre Vainchtock
Eur J Obstet Gynecol Reprod Biol - 2009

L'utilisation de la base nationale PMSI pour déterminer le coût d'un symptôme : le cas de la neutropénie fébrile
Alexandre Vainchtock
Journal d’Économie Médicale - 2007

Papers

Disparities in lung cancer incidence and management care in France: a nationwide cohort study
Cécile Blein /Alexandre Vainchtock/benoit saitta
WCLC - 2015

Access to innovative drugs in patients with metastatic lung cancer in French public hospitals (the TERRITOIRE study)
Cecile BLEIN Benoit SAITTA Alexandre Vainchtock
ISPOR 2015 - 2015

Entre honoraires et revenus : les charges » - l'offre médicale par spécialité d'exercice
Cécile BLEIN/Baptiste JOUANETON
Colloque SENAT LE BLOC, Dépassements d’honoraires et tarifs opposables » : analyse et propositions - 2012

Retrospective study on five DRG follow-up in French casemix 2009 analysis for the determination of quality indicators in P4O reforms

Congrès Patient Classification Sytems - 2012

Evaluation des taux de regrets au sein de la population de femmes stérilisées : Utilisation des bases PMSI MCO de 2006 à 2010
Ludovic LAMARSALLE
Université des Pharmaco-Epidémiologiques - 2011

Posters

The cost of thromboembolic events in hospitalized patients : a stdy on four major cancer localizations
Alexandre vainchtock
ESMO - 2015

Thromboembolic Events in Hospitalized Cancer Patients: Impact on stay duration and cost for four majour cancer localizations
cécile BLEIN
ASCO palitaive care - 2015

OF MELANOMA IN FRANCE IN THE ADVANCED/METASTATIC SETTING: THE MELISSA STUDY (MELANOMA IN HOSPITAL COSTS ASSESSMENT)
Lucie de LEOTOING/ Camille Amaz / Alexandre Vainchtock
ESMO - 2015

Accès aux médicaments de la « liste en sus » chez les patients atteints de cancer du poumon métastatiques (étude TERRITOIRE)
Cécile Blein /Alexandre Vainchtock/benoit saitta
CPLF (congrès de Pneumologie de Langue Française) - 2015

Disparités régionales et socio-économiques dans le cancer du poumon (étude TERRITOIRE)
Cécile Blein /Alexandre Vainchtock/soline leblanc
CPLF (congrès de Pneumologie de Langue Française) - 2015

en attente
Lucie de LEOTOING/ Alexandre Vainchtock
ISPOR 2015 - 2015

MODELING OF CLINICAL PATHWAYS IN THE IMPLANTATION OF CARDIOVERTER DEFIBRILLATORS FROM 2006 TO 2013 USING THE FRENCH HOSPITAL P.M.S.I. DATABASE
Prodel M, Jouaneton B, Lamarsalle, Vainchtock
ISPOR 2015 - 2015

"Modelisation du parcours patient dans l’implantation de Defibrilateurs cardiaques de 2006 a 2013 a partir du pmsi "
Prodel M.a, Jouaneton B.a, Lamarsalle La
8 èmes JGS Nimes 2015 - 2015

Impact du recueil de l’indicateur de mortinatalite sur le codage des naissances au sein du pmsi entre les annees 2011 et 2013
Blein C, Chaise G, Lamarsalle L, Vainchtock A
8 èmes JGS Nimes 2015 - 2015

Incidence and costs of thromboembolic events in cancer patients: a study on four major cancer localizations
Alexandre VAINCHTOCK
ASCO - 2015

Incidence and costs of thromboembolic events in cancer patients: a study on four major cancer localizations
Alexandre VAINCHTOCK
ASCO - 2015

Le syndrome de grêle court (SGC) en France chez l’adulte. Données épidémiologiques à partir du PMSI
Cécile BLEIN
JFHOD 2015 - 2015

Features And Causes Of Death Of Patients With Atrial Fibrillation Seen In French Hospitals In 2012
Gwendoline CHAIZE/Alexandre VAINCHTOCK
AHA Scientific Sessions - 2014

The cost of thromboembolic events in hospitalized patients with colon or lung cancer in France
Alexandre VAINCHTOCK
ASH - 2014

VTE-related hospital costs for patients with breast or prostate cancer
Alexandre VAINCHTOCK
MASCC - 2014

Thromboembolic Events in Breast and Prostate Cancer Patients hospitalized in 2011 and 2012: incidence and costs
Alexandre VAINCHTOCK
ESMO - 2014

Thromboembolic Events in Breast and Prostate Cancer Patients hospitalized in 2011 and 2012: incidence and costs
Alexandre VAINCHTOCK
ASCO PAL - 2014

The cost of thromboembolic events in hospitalized patients with breast or prostate cancer in France
Alexandre VAINCHTOCK
ASCO - 2014

Le fardeau des hospitalisations liées à l’hépatite C chronique en France :Evolution entre 2009 et 2012
Lucie de LEOTOING
75èmes Journées Scientifiques de l’AFEF - 2014

Prise en charge hospitalière de la leucémie aigüe lymphoblastique (LAL) en 2012 : données du Programme de Médicalisation des Systèmes d’Information (PMSI)
Remerciement HEVA
Congrès annuel de la Société Française d’Hématologie - 2014

Prise en charge hospitalière du purpura thrombopéniqueimmunologique (PTI) chez l’adulte en France en 2012 : données du Programme de Médicalisation des Systèmes d’Information (PMSI)
Remerciement HEVA
Congrès annuel de la Société Française d’Hématologie - 2014

Burden of cardiovascular complications in patients with atrial fibrillation in France
Gwendoline CHAIZE/Alexandre VAINCHTOCK
ISPOR 17th Annual European Congress - 2014

Burden of hospitalizations related to chronic hepatitis C in France: evolution between 2009 and 2012
Lucie de Leotoing/Alexandre VAINCHTOCK
ISPOR 17th Annual European Congress - 2014

Hospital cost of thromboembolic events in breast or prostate cancer patients
Alexandre VAINCHTOCK
ISPOR 17th Annual European Congress - 2014

Mean annual cost of patients hospitalized for chronic hepatitis C in France: the HEPC-LONE study
Lucie de Leotoing/Alexandre VAINCHTOCK
ISPOR 17th Annual European Congress - 2014

Hospital Costs of Thrombocytopenia Related to Hepatitis C Virus Infection : Analysis of the French Hospital Discharge Database
Alexandre VAINCHTOCK
48th Annual Meeting of the European Association for the Study of the Liver - 2013

Analysis of public and private hospital databases (PMSI) 2010 / 2011 to estimate the frequency and associated costs for febrile neutropenia in France
Alexandre VAINCHTOCK
ISPOR 16th Annual European Congress - 2013

Analysis of re-hospitalisations for stroke and transient ischemia recurrence and associated costs in the burgundy region in France
Rémi MARTY/Baptiste JOUANETON/Stéphane ROZE
ISPOR 16th Annual European Congress - 2013

Zona à l'hôpital en France : Quels patients ? Quel type d'hospitalisation ? Quel coût ?
Alexandre VAINCHTOCK/ Cécile BLEIN
Journées Annuelles de la Société Française de Gériatrie et Gérontologie JASFGG 2013 - 2013

Evaluation of the herpes zoster impact as comorbidity factor in 5 pathologies french hospital care among adults aged 50 and older
Cécile BLEIN/Alexandre VAINCHTOCK
ISPOR 16th Annual European Congress - 2013

Analysis of hospital-specific drg payments for stroke according to united states medicare perspective
Cécile BLEIN/Rémi MARTY/Stéphane ROZE
ISPOR 15th Annual European Congress - 2012

2-year incidence of stroke and hemorrhages hospitalizations and costs within atrial fibrillation patients in France
Gwendoline CHAIZE/Alexandre VAINCHTOCK
ISPOR 15th Annual European Congress - 2012

4-year incidence and costs of hospitalized complications within kidney transplant patients in France
Alexandre VAINCHTOCK/Gwendoline CHAIZE
ISPOR 15th Annual European Congress - 2012

Preventing alzheimer disease: is there a place for cost-effective interventions? dynamic modeling applied to a pan european analysis
Stephane ROZE/Alexandre VAINCHTOCK/ Remi MARTY
ISPOR 15th Annual European Congress - 2012

Hospital costs related to hepatitis C virus infection: first analysis of the French hospital national data base
Alexandre VAINCHTOCK/ Baptiste JOUANETON
ISPOR 14th Annual European Congress - 2011

Hospitalisation costs for HPV-related cancers in males and females in France
Remerciement HEVA
ISPOR 13th Annual European Congress - 2010

Cost of management of breast cancer with brain metastases using French hospital patient chaining system
Alexandre VAINCHTOCK
ISPOR 13th Annual European Congress - 2010

Economic Burden of Osteoporosis in Women; Data From the 2008 French Hospital Database
Alexandre VAINCHTOCK/ Baptiste JOUANETON
ASBMR 32 Annual meeting - 2010

Economic burden of osteoporosis-related fracture hospitalizations in France
Alexandre VAINCHTOCK/ Baptiste JOUANETON
ISPOR 13th Annual European Congress - 2010

Analysis of hospital events meaning iatrogenicity, anhemia
Alexandre VAINCHTOCK/Ludovic LAMARSALLE
ISPOR 12th Annual European Congress - 2009

Budget impact model for determining the hospital costs of introducing prasugrel for the long term treatment of acute coronary syndrome treated by percutaneous coronary intervention in France
Alexandre VAINCHTOCK
ISPOR 12th Annual European Congress - 2009

Hospitalisations for head and neck cancers in France
Alexandre VAINCHTOCK
ISPOR 12th Annual European Congress - 2009

Vulvar and vaginal diseases in France: evaluation from hospital stays
Alexandre VAINCHTOCK
Eurogin Conference - 2008

Hospitalisation and management costs of patients with penile cancer in France
Alexandre VAINCHTOCK
16th United European Gastroenterology Week - 2008

Hospitalisation and management costs of patients with anal cancer in France
Alexandre VAINCHTOCK
16th United European Gastroenterology Week - 2008

Managament costs of patients with vulvar and vaginal cancer in France
Alexandre VAINCHTOCK
ISPOR 11th Annual European Congress  - 2008

Use of an administrative database to estimate the number of hospital admissions for immune thrombocytopenic purpura and its economic burden in France
Alexandre VAINCHTOCK
ISPOR 11th Annual European Congress  - 2008

Use of an administrative database to estimate the economic burden of febrile neutropenia
Alexandre VAINCHTOCK
ISPOR Tenth Annual European Congress - 2007

Contact us